Vitamin D Supplementation in Children With Sickle Cell Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
Children aged 6 months to 12 years of age will be randomised to receive vitamin D 60,000IU once a month for 3 months or a placebo. The vitamin D will be in form of granules supplied in sachets. The primary study outcomes will be incidence of hospitalisation and change in vitamin D levels following supplementation. Secondary outcomes will include incidence of vaso-occlusive crisis (VOC), acute severe respiratory illness, Vitamin D related Severe adverse events and requirements for blood transfusion
Epistemonikos ID: df5ec48288755e6795d9f40075655cc4025e45c3
First added on: Dec 20, 2022